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higher LDL cholesterol (13.7 vs. 12.8 mg/dL, p=0.07). By contrast, there were
no differences between the two groups as regards duration of HIV infection,
time of exposure to ARVs, (whether considered as a whole or by class), us-
CRP, or IL-6. Of the 45 patients with an abnormal CACS, 41 (91.1%) had
FRS <20% and would not have been eligible for cardiovascular prevention
treatment. These 41 patients represented 22.9% of all patients with FRS <20.
None of the 5 patients with CACS > 300 had been identified as high cardio-
vascular risk patients by FRS. 
Conclusion: In HIV-infected patients, CACS identified presence of coro-
nary atherosclerosis in 22.9% of patients who were deemed to be at low to
intermediate cardiovascular risk based on FRS. 
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Purpose: it has been postulated that outcome of poor metabolizers of clop-
idogrel may be worse in ACS patients. Data about the interest of assessing
platelet reactivity and genotyping in predicting outcome of patients with ACS
taking clopidogrel is still conflicting.
Methods: Prospectively, 120 successive patients (76,7% men, mean
age=60+/–12,2 years) with ACS 45% STEMI) were included. Patients were
excluded if not eligible to clopidogrel therapy or to the platelet activity test.
Patients were managed according to ESC guidelines. Platelet activity was assessed
by a VerifyNow P2Y12 test more than 24h after a 600mg clopidogrel loading
dose. DNA was extracted for genotyping of CYP1A1 and CYP2C19
(*1,*2,*3).MACE (death, infarction, stroke, coronary revascularization) was
assessed at 6 months.
Results: poor platelet inhibition (PRU>230) was noted 54 (46,6%) patients.
CYP1A1 and CYP2C19 low metabolizers (homo and heterozygosis) were respec-
tively 23.1% and 37,5%. MACE at 6 months was noted in 15 (12.5%) patients.
No significant correlation was found between MACE and platelet reactivity test
nor MACE and genotypes CYP1A1 and CYP2C19. combination of platelet
response and resistant genotypes didn’t help to predict MACE.
Conclusion: despite the high rates of poor responders to clopidogel in this
study, assessed by the verify now P2Y12 test and by genotyping (CYP1A1
and CYP2C19), no correlation has been found with MACE at 6 months.
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Introduction: In front of an important request for examination of myo-
cardal scintigraphy following a test of “litigious” effort, we are propose to
complete this work futurology with an aim of answering the question sug-
gested in title, in referent with the results of the myocardial tomoscintigraphy.
Materials and methods: Between January 2008 and May 2010, we investigate
186 consecutive patients presenting of the coronary risk factors addressed for
myocardal tomoscintigraphy in front of a test of litigious effort on the electric
level carried out within the framework of a search for quiet ischemia. Within
the service of nuclear medicine all the patients profited from a test of effort
according to the protocol of Bruce, followed by an examination tomoscintig-
raphy with the MIBI. In the event of a disorder perfusionnel with the myo-
cardic scintiscanning, the patient is taken again for an examination of rest. 
Results: There are 105 women and 81 men whose Middle Age is respec-
tively of 57,4 ± 9,3 years and 59,6 ± 8,2 years. The patients are diabetics in
66% of the cases, 78% are women, hypertensive in 53%. The other risk fac-
tors are also found with variable proportions. The tests of effort carried out
were all maximum. Four 92% of the tests of effort are negative clinically and
“wrongfully positive” electrically. The TSM of these patients is normal in
100% of the cases. In 8% of the cases, the test of effort is positive electrically,
the TSM is normal not detecting any disorder perfusionnel in 73% of the
cases, for the 4 other patients it objectifies disorders perfusionnels; the coron-
arography of these patients is pathological but without significant lesions
except for a patient. This last had in fact finished its test of effort by a non-
constant ventricular tachycardia suggesting a severe ischaemia confirmed with
the coronarography. 
Conclusion: A quite critical reading of under misalignment of the segment
ST during a test of effort diagnoses in particular at the time of the search for
a quiet ischemia, can avoid the recourse to other investigations
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Purpose: the aims of this study were to evaluate the novel biomarker
copeptin in combination with troponin I (cTnI), in patients with chest pain
presenting to the emergency department (ED), and to determine whether
copeptin may allow for a rapid rule out of acute myocardial infarction (AMI).
Previous data showed that combined measurement of copeptin and troponin
T(cTnT) improved diagnostic performance for rapid rule out of AMI.
Methods: in 97 patients presenting to the ED with suspicion of AMI, we
performed at admission, a conventional cTnI assay and a novel copeptin
assay.
Results: of 97 patients, 44 (45.4%) had the final diagnosis of AMI,
11(11.3%) of unstable angina and in 42 (43.3%) an acute coronary syndrome
(ACS) could be excluded. Patients with AMI, had copeptin levels higher than
patients with non ACS (20.12 vs 8.97pmol/l p<0.001). At admission, the aera
under curve (AUC) of the receiver-operating characteristic (ROC) curve for
the association cTnI / copeptin was not higher than AUC of cTnI (respectively
0.93 vs 0.89; p=0.177). In 60 patients with negative cTnI (< 0.044 μg/L),
copeptin (< 14 pmol/L) may allow to rule out AMI with sensitivity of 91.0%
and negative predictive value (NPV) of 97.4%.
Conclusions: conversely to what has been demonstrated for cTnT, no sig-
nificant difference in AUC was found when Copeptin/cTnI was compared to
cTnI alone. This can be explained by the limited set of patients and the rela-
tive good result of cTnI AUC. Only combined use of copeptin in negative
cTnI patients might help in ruling out AMI because of its good NPV and
hence improve triage of patients presenting with chest pain in ED.
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Purpose: The aim of this work is to study the specific epidemiological,
clinical, angiographic and evolving myocardial infarction (MI) of the young
subject.
Materials and methods: It is a descriptive retrospective study ruled in the
two services of cardiology of the UHC Mohammed VI de Marrakech from
January 2005 to October 2009. We included the patients admitted for MI and
paired them in two groups: group1 composed of young patients under 45 years
for men and 55 years for women, and group 2 of old patients beyond these age
limits. Patients in both groups were investigated focusing in epidemiological
analysis of cardiovascular risk factors, an ECG, a biological assessment and a
Doppler ultrasound cardiac examination (TTE). The coronarography wasn’t
realized in all cases. 
© Elsevier Masson SAS. All rights reserved.
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Results
The coronarography was realized in 10 cases of group 1 and 14 of group
2. It visualized especially impairment mono tronculaire in group 1, by cons
multitronculaires injuries are frequently encountered in group 2.The hospital
mortality was lower in young compared with older subjects. 
Conclusion: The MI of the young subject is inaugural in the majority of
cases and occurs especially at rest. Smoking and dyslipidemy are the indepen-
dent factors of risk. The coronary lesions are non significant or readily mono
tronculaires. 
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Introduction: Acute coronary syndrome (ACS) is common in diabetics
and severe, the severity of coronary lesions and multiplying cardiovascular
risk are likely to role in this adverse trend.
Objectives: The aim of this study was to determine the clinical and angi-
ographic characteristics, treatment and development of ACS in diabetics (D)
compared to nondiabetic (ND). 
Methods: From January 2010 through April 2011, 452 patients with ACS
were hospitalized in the cardiology department of the CHU Ibn Rochd in Cas-
ablanca Morocco, they included 202 D and 250 ND.
Results: Comparison of these two groups showed a younger age with a
mean age of 51.4 years and a higher percentage of men (59%) among the D,
hypertension was more frequent in D, while smoking was frequent in both
groups. 
Hospitalization was the reason for ACS without ST segment elevation in
54.3% in the D group versus 43.8% in the ND group (p=0.03) and for ACS
with persistent ST segment elevation in 45.6% in the D group versus 56,1%
in the ND group (p=0,02). 
Coronary angiography showed: Table I
Table I – results of coronary angiography
The syntax score calculated in the D was above 33 in 38.5% versus 11.4%
in the ND, treatment was similar in both groups, 209 patients underwent myo-
cardial revascularization, and its method (thrombolysis or coronary angio-
plasty or coronary artery bypass graft) did not differ by group. Neither
hospital mortality nor other complications differed between the two groups.
Conclusion. The ACS in diabetics occurs at a younger age with a male
predominance, coronary lesions are more extensive, more severe, often multi-
vessel and distal.
Correct management of ACS and close collaboration between cardiologists
and endocrinologists should improve prognosis for patients with diabetes.
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Introduction: the treatment of ST segment elevation myocardial infarction
is to restore permeability of the responsible coronary artery; the goal of our
work is to illustrate the benefit of primary angioplasty as an alternative to
thrombolysis. 
Materials and methods: This is a retrospective study concerning 75
patients admitted for ST segment elevation myocardial infarction, between
January 2008 and February 2010, divided into 2 groups: group [1] n=30,
treated by primary angioplasty, compared to the group [2] n=45 thrombolysed.
Results: the average age of our patients is 56.6 ± 6.7 years (group 1) and
55.4 ± 5.9 years (group 2), male is predominant in the 2 groups, most of
patients had more than 2 cardiovascular risk factors in the 2 groups.
The time between chest pain and admission to the emergency department
is 231min in group 1 versus 247min in group 2, and the period of reperfusion
is 281 min in group 1 (door to baloon) versus 277min (onset of chest pain to
thrombolysis). 
The coronary angiography showed three vessel lesions in 30% [group 1]
versus 26% [Group 2], two vessel lesions in 23% [group 1] versus 18%
[Group 2] and a single-vessel-disease in 47% [group 1] versus 56% [group 2]. 
In group 1, in addition to medical treatment and primary angioplasty, 3.3%
had undergone coronary artery bypass grafting, in group 2, after thrombolysis,
24% benefited from angioplasty, 20% had CABG and 56% was treated med-
ically.
Primary angioplasty has been marked by a primary success, the outcome
was good in 83%, stent thrombosis occurred only in 2 cases. 
In the second group, the outcome was favourable in only 46%, we
deployed a single death due to cardiogenic shock and complications like left
ventricular dysfunction in 13%, angina in 13% and arrhythmia in 3%. 
Conclusion: the choice of basic therapy in STEMI is mainly based not
only on accessibility to the angiography room but on angioplasty reperfusion
(door to balloon), as well, when it is available, the angioplasty is highly rec-
ommended. 
Group 1 
N=30
Group 2
N=30
Value of P
Average age (years) 44.5±4,2 56,7±6,3 <0,01
Smoking 67% 64% NS
Dyslipidemy 50% 27% 0,01
Diabetes 37% 39% NS
Hypertension 13% 22% 0,01
Inaugural MI 83% 34% <0.001
MI occuring at rest 97% 57% <0.001
Anterior topography 70% 55% <0.05
MI none Q 37% 17% 0.01
Normal TTE 27% 15% <0.01
Dilatation of LV 3% 48% <0.001
LV: left ventricle
Diabetic 
patients
Nondiabetic 
patients
p value
normal coronary angiogram 13% 28% 0.002
single vessel coronary diseases 24% 42% 0.008
two-vessel coronary disease 27% 19% 0.15
multivessel coronary artery disease 35% 11% 0.0000
1
long coronary disease 69% 28% 0.0001
distal coronary disease 41% 19% 0.0001
anterior interventricular artery disease 49% 54% 0.449
left circumflex artery disease 19% 20% 0.9
right coronary artery disease 32% 26% 0.34
